Sequential versus concomitant non-bismuth quadruple therapy as first-line eradication for helicobacter pylori

被引：0
|
作者：
Pereira, F. [1 ]
Azevedo, R. [1 ]
Linhares, M. [1 ]
Ramos, D. [1 ]
Pinto, J. [1 ]
Caldeira, A. [1 ]
Tristan, J. [1 ]
Pereira, E. [1 ]
Sousa, R. [1 ]
Banhudo, A. [1 ]
机构：
[1] Hosp Amato Lusitano, Castelo Branco, Portugal
来源：
NEUROGASTROENTEROLOGY AND MOTILITY | 2019年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
208
引用
收藏
页数：2
相关论文
共 50 条
  • [31] The effects of sequential treatment as a first-line therapy for Helicobacter pylori eradication
    Demir, Mehmet
    Ataseven, Hilmi
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2011, 41 (03) : 427 - 433
  • [32] Efficacy of Sequential Therapy as the First-Line Treatment in the Eradication of Helicobacter pylori
    Tamene, Yonas
    Mody, Shefali P.
    Sadiq, Kaiser O.
    Shivakumar, Yogamba M.
    Burra, Eshwar
    Shahid, Kamran
    Nath, Tuheen Sankar
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [33] Comparison of the traditional triple and a new bismuth-containing quadruple therapy in the first-line eradication of Helicobacter pylori
    Varga Mate
    Dracz Lajos
    Kolbenheyer Erik
    Varga Ferenc
    Patai Arpad, V
    Solymosi Norbert
    Patai Arpad
    ORVOSI HETILAP, 2019, 160 (34) : 1340 - 1345
  • [34] Cuadruple concomitant non-bismuth therapy vs. classical triple therapy as first line therapy for Helicobacter pylori infection
    Campillo, Ana
    Ostiz, Miriam
    Amorena, Edurne
    Kutz, Marcos
    La Iglesia, Matilde
    MEDICINA CLINICA, 2016, 147 (05): : 199 - 201
  • [35] Bismuth containing quadruple therapy for second line Helicobacter pylori eradication
    Lee, M.
    Lee, B.
    Kim, G.
    Park, E.
    Jeon, H.
    Song, G.
    HELICOBACTER, 2017, 22
  • [36] First-line Bismuth-containing Five-day Concomitant Quintuple Therapy for Helicobacter Pylori Eradication
    Dolapcioglu, Can
    Sayiner, Mehmet
    Akkus, Esra Elif
    Kural, Abdulaziz
    Dolapcioglu, Hatice
    Dabak, Resat
    Ahishali, Emel
    HELICOBACTER, 2016, 21 (02) : 100 - 105
  • [37] Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy
    Song, Zhiqiang
    Zhou, Liya
    Zhang, Jianzhong
    He, Lihua
    Bai, Peng
    Xue, Yan
    DIGESTIVE AND LIVER DISEASE, 2016, 48 (05) : 506 - 511
  • [38] First-line treatment of Helicobacter pylori in Lebanon: Comparison of bismuth-containing quadruple therapy versus 14-days sequential therapy
    Tarhini, Mandi
    Fayyad-Kazan, Mohammad
    Fayyad-Kazan, Hussein
    Mokbel, Mahmoud
    Nasreddine, Mohammad
    Badran, Bassam
    Kchour, Ghada
    MICROBIAL PATHOGENESIS, 2018, 117 : 23 - 26
  • [39] NON-BISMUTH QUADRUPLE "CONCOMITANT" THERAPY VERSUS STANDARD TRIPLE THERAPY FOR CLARITHROMYCIN-SUSCEPTIBLE H. PYLORI AND VERSUS QUADRUPLE "SEQUENTIAL" THERAPY FOR CLARITHROMYCIN-RESISTANT H. PYLORI
    Molina-Infante, J.
    Pazos-Pacheco, C.
    Vinagre-Rodriguez, G.
    Hernandez-Alonso, M.
    Martin-Noguerol, E.
    Gonzalez-Santiago, J. M.
    Duenas-Sadornil, C.
    Gonzalez-Garcia, G.
    Fernandez-Bermejo, M.
    Gisbert, J. P.
    HELICOBACTER, 2011, 16 : 135 - 136
  • [40] First-line treatment of helicobacter pylori in Lebanon: Comparison of bismuth-containing quadruple therapy versus 14-days sequential therapy
    Tarhini, M.
    Fayyad-Kazan, M.
    Fayyad-Kazan, H.
    Mokbel, M.
    Nasreddine, M.
    Badran, B.
    Kchour, G.
    CLINICA CHIMICA ACTA, 2024, 558
12345